Recombinant Gloeobacter violaceus Trigger factor (tig)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If a specific tag type is required, please inform us for preferential development.
Synonyms
tig; glr4195; Trigger factor; TF; EC 5.2.1.8; PPIase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-461
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Gloeobacter violaceus (strain PCC 7421)
Target Names
tig
Target Protein Sequence
MKVTQEKLPR SQMGLNVEVE GEKSKQAYEK LVRDTMRTAR IPGFRPGKAP RQLVLQFYGK ERLRAQALEN LIDSSLKEAI EQESIASLGN LQLRDSFEEL LGRYQPGEPL SFKAAVDVQP EVQLGTYTGL TVRYSEVPYE AKQVDDQLEQ YREQRAVLVP VEGRAAEVGD TAVIDFAGTK AADGNEIVGG KATDFEVELL PGRLIAGFTE GIIGMQIGES TELALRFPDD YPQQELAGVD AKFAVSLKDL KIKELPVLDD DFAGDISEFE TLEALRAFLE QQQQEQAAEK TRANRDAAII KALVAETTVD LPETLVNREV QFLAEQSFRN LQQQGIDPSR IFTEENMPRV RETLRVDAEN RLKRTLALAQ VARAENIVVE EEQVAARIVE LRSELEEEVS EQALAEFARE EMLTEKILEW LAEHSTIELT LPGEAIEPGS GEDAPPEVAA GATEPEAQPN S
Uniprot No.

Target Background

Function

Involved in protein export. Functions as a chaperone, maintaining newly synthesized proteins in an open conformation. Also functions as a peptidyl-prolyl cis-trans isomerase.

Database Links

KEGG: gvi:glr4195

STRING: 251221.glr4195

Protein Families
FKBP-type PPIase family, Tig subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Trigger factor (tig) in Gloeobacter violaceus and how does it function?

Trigger factor (tig) in Gloeobacter violaceus is a molecular chaperone that likely exhibits peptidyl-prolyl cis/trans isomerase (PPIase) activity similar to its homologs in other bacteria such as E. coli. Trigger factor binds to nascent polypeptide chains as they emerge from the ribosome, facilitating their proper folding and preventing aggregation. The protein was originally identified as a molecule that could bind to certain precursor proteins, though subsequent research has established its primary role in protein folding rather than protein transport . While G. violaceus-specific TF has not been extensively characterized in the available literature, it likely shares the domain structure conserved in the FK506-binding protein family, typical of bacterial trigger factors .

What structural characteristics define G. violaceus Trigger factor?

Based on homology with other bacterial trigger factors, G. violaceus Trigger factor likely possesses a three-domain architecture consisting of:

  • An N-terminal ribosome-binding domain

  • A central PPIase domain with enzymatic activity

  • A C-terminal domain involved in substrate binding

Which expression systems yield optimal results for recombinant G. violaceus Trigger factor?

E. coli expression systems typically provide the best yields and shortest turnaround times for recombinant Trigger factor production . For G. violaceus Trigger factor specifically, the following expression strategies may be considered:

  • E. coli expression: Provides high yields and rapid production. Consider using BL21(DE3) or derivatives with controlled expression systems such as the arabinose-inducible araBAD promoter or tetracycline-inducible Pzt-1 promoter systems similar to those used for E. coli Trigger factor .

  • Yeast expression: Offers good yields with some eukaryotic post-translational modifications. Pichia pastoris or Saccharomyces cerevisiae systems may be suitable alternatives when E. coli expression results in insoluble protein .

  • Insect cell expression: When proper folding requires more complex post-translational modifications, baculovirus expression systems in Sf9 or Hi5 cells can be employed .

  • Mammalian cell expression: Typically provides the most native-like post-translational modifications but with lower yields and higher costs .

For most research applications, E. coli expression using a controlled induction system similar to the pTf16 plasmid (with arabinose-inducible promoter) described for E. coli Trigger factor would be the recommended starting point .

What strategies can prevent aggregation of recombinant G. violaceus Trigger factor during expression?

Preventing aggregation of recombinant G. violaceus Trigger factor may require several strategic approaches:

  • Lower induction temperature: Reducing the temperature to 18-25°C during protein expression can slow folding kinetics and reduce aggregation.

  • Co-expression with chaperones: Ironically, co-expressing Trigger factor with other molecular chaperones like GroEL-GroES or DnaK-DnaJ-GrpE can improve its solubility, similar to how these systems work synergistically for other recombinant proteins .

  • Controlled expression rate: Using weaker promoters or lower inducer concentrations to slow the rate of protein synthesis, allowing more time for proper folding.

  • Fusion tags: N-terminal solubility-enhancing tags such as MBP (maltose-binding protein), SUMO, or Thioredoxin can improve solubility.

  • Buffer optimization: Including stabilizing agents such as glycerol, specific salts, or mild detergents in lysis buffers can maintain protein solubility during purification.

Based on research with E. coli Trigger factor, these approaches can be effective individually or in combination, depending on the specific challenges encountered with G. violaceus Trigger factor expression .

How can optimal purification of G. violaceus Trigger factor be achieved?

A multi-step purification strategy is typically required for obtaining high-purity recombinant G. violaceus Trigger factor:

  • Initial capture: Affinity chromatography using histidine, GST, or other fusion tags provides efficient initial purification. His-tag purification using Ni-NTA resin is particularly effective for trigger factors.

  • Intermediate purification: Ion exchange chromatography (typically anion exchange at pH 8.0) can separate the target protein from similarly charged contaminants.

  • Polishing: Size exclusion chromatography (gel filtration) as a final step to remove aggregates and obtain highly pure, monodisperse protein.

  • Tag removal: If necessary, proteolytic removal of fusion tags using TEV, PreScission, or other site-specific proteases, followed by a second affinity step.

Buffers should be optimized to maintain Trigger factor stability, typically containing:

  • 20-50 mM Tris or phosphate buffer (pH 7.5-8.0)

  • 100-300 mM NaCl

  • 1-5 mM DTT or β-mercaptoethanol

  • 5-10% glycerol

Assessing protein activity throughout purification is essential to ensure that the native conformation and chaperone function are maintained.

What experimental approaches can verify the chaperone activity of G. violaceus Trigger factor?

Several experimental approaches can be employed to assess the chaperone activity of G. violaceus Trigger factor:

  • Aggregation prevention assays: Measuring the ability of Trigger factor to prevent aggregation of model substrates like citrate synthase or firefly luciferase under thermal or chemical stress using light scattering techniques.

  • Co-expression studies: Similar to those performed with E. coli Trigger factor, co-expressing G. violaceus Trigger factor with aggregation-prone proteins like endostatin, ORP150, or lysozyme and analyzing the soluble versus insoluble fractions .

  • Ribosome binding assays: Using sucrose gradient centrifugation or surface plasmon resonance to assess binding to ribosomes, which is critical for Trigger factor function.

  • PPIase activity assays: Measuring the rate of proline isomerization using model substrates like N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide.

  • Fluorescence-based folding assays: Using fluorescent proteins or FRET-based reporters to monitor protein folding in the presence and absence of Trigger factor.

The approach used with E. coli Trigger factor, where its effect on preventing aggregation of co-expressed recombinant proteins was analyzed by SDS-PAGE of soluble versus insoluble fractions, provides a straightforward methodology that could be adapted for G. violaceus Trigger factor .

How does G. violaceus Trigger factor potentially interact with cyanobacterial-specific proteins?

G. violaceus is a primitive cyanobacterium with unique photosynthetic machinery, suggesting its Trigger factor may have evolved specialized interactions with these systems. While direct evidence is limited in the search results, several hypotheses can guide research:

  • Photosynthetic protein folding: G. violaceus Trigger factor might be particularly adapted to facilitate folding of photosynthetic proteins, such as components of photosystems I and II, which are absent in E. coli.

  • Interaction with transcriptional regulators: Similar to how GvTcR (G. violaceus transcriptional regulator) interacts with other regulatory proteins , Trigger factor might participate in regulatory networks specific to this cyanobacterium.

  • Potential synergy with rhodopsin systems: Given the presence of Gloeobacter rhodopsin (GR) in this organism , Trigger factor might have co-evolved to assist in the folding of this or related membrane proteins.

Experimental approaches to investigate these possibilities include:

  • Co-immunoprecipitation coupled with mass spectrometry to identify interaction partners

  • Yeast two-hybrid or bacterial two-hybrid screening against a G. violaceus cDNA library

  • Comparative binding studies with specific photosynthetic proteins

How can site-directed mutagenesis help elucidate G. violaceus Trigger factor function?

Site-directed mutagenesis represents a powerful approach for dissecting the functional domains and mechanisms of G. violaceus Trigger factor:

  • Ribosome binding mutants: Mutations in the N-terminal domain can disrupt ribosome binding and help determine if ribosome association is essential for all chaperone activities or if some functions are ribosome-independent.

  • PPIase domain mutants: Mutations in catalytic residues of the PPIase domain can distinguish between isomerase-dependent and isomerase-independent chaperone functions, similar to findings with E. coli Trigger factor that binding to some substrates is independent of proline residues .

  • Substrate binding region mutations: Alterations in the C-terminal substrate-binding domain can help identify specific regions responsible for interaction with different client proteins.

  • Inter-domain communication: Mutations at domain interfaces can reveal how conformational changes are transmitted between domains during the chaperone cycle.

A methodical mutagenesis approach should:

  • Start with conserved residues identified through sequence alignment with better-characterized trigger factors

  • Create single point mutations followed by combinatorial mutations

  • Assess each mutant for ribosome binding, PPIase activity, and chaperone function

  • Compare results with known mutations in E. coli Trigger factor to identify shared and divergent functional features

How does G. violaceus Trigger factor potentially interact with other chaperone systems?

Trigger factor in E. coli is known to function synergistically with other chaperone systems, particularly GroEL-GroES, and this relationship may exist with G. violaceus Trigger factor as well:

  • Synergistic effects: Studies in E. coli demonstrated that simultaneous overexpression of Trigger factor and GroEL-GroES was more effective for preventing aggregation of certain proteins (ORP150 and lysozyme) than either chaperone system alone, suggesting cooperative roles in protein folding .

  • Sequential actions: Trigger factor likely acts as a first-line chaperone interacting with nascent chains, followed by downstream chaperones like DnaK-DnaJ-GrpE or GroEL-GroES when needed for more complex folding pathways.

  • Physical interactions: E. coli Trigger factor has been shown to bind to GroEL and increase its affinity for certain proteins, facilitating their folding or degradation . Similar physical interactions may exist in the G. violaceus chaperone network.

  • Functional overlap: Research with E. coli indicated that Trigger factor and the DnaK-DnaJ-GrpE system have partially overlapping functions in folding nascent polypeptides , a relationship that likely extends to G. violaceus.

Experimental approaches to study these interactions include co-immunoprecipitation, in vitro reconstitution of the chaperone network, and genetic studies with chaperone deletion/overexpression strains of G. violaceus or heterologous systems.

What role might G. violaceus Trigger factor play in stress response mechanisms?

Although the search results don't specifically address the role of G. violaceus Trigger factor in stress response, several hypotheses can be formulated based on knowledge of bacterial chaperones:

  • Temperature stress: Trigger factor likely plays an enhanced role during cold shock, as lower temperatures increase the risk of protein misfolding during translation.

  • Oxidative stress: G. violaceus, as a photosynthetic organism, faces unique oxidative challenges that may require specialized Trigger factor functions to protect nascent chains from oxidative damage.

  • Light stress: As a cyanobacterium, G. violaceus experiences varied light conditions that affect photosynthetic machinery, potentially requiring Trigger factor assistance in repairing or replacing damaged photosystem components.

  • Nutrient limitation: During starvation, Trigger factor might shift from primarily assisting folding to also facilitating controlled degradation of certain proteins, similar to the dual role observed with E. coli Trigger factor .

Research into these aspects could employ transcriptomic and proteomic analyses of G. violaceus under various stress conditions, coupled with assessments of Trigger factor expression, localization, and interaction partners.

How can structural biology techniques be applied to study G. violaceus Trigger factor?

Advanced structural biology approaches can provide crucial insights into G. violaceus Trigger factor function:

Each of these approaches offers complementary information, and a comprehensive structural characterization would ideally combine multiple techniques to build a complete picture of G. violaceus Trigger factor structure and dynamics.

How can G. violaceus Trigger factor be utilized to enhance heterologous protein expression?

G. violaceus Trigger factor could potentially be employed as a folding assistant for heterologous protein expression, similar to E. coli Trigger factor:

  • Co-expression strategy: Developing plasmid systems for controlled co-expression of G. violaceus Trigger factor with target proteins, similar to the pTf16 and pG-Tf2 plasmids used for E. coli Trigger factor .

  • Expression optimization: Adjusting the relative expression levels of Trigger factor and the target protein through promoter selection and induction conditions to achieve optimal folding assistance.

  • Combinatorial chaperone approach: Co-expressing G. violaceus Trigger factor with other chaperones (GroEL-GroES or DnaK-DnaJ-GrpE) for enhanced folding of difficult targets, utilizing the synergistic effects observed with E. coli chaperones .

  • Host strain engineering: Developing expression strains with genomically integrated G. violaceus Trigger factor under controllable promoters for stable and reproducible co-expression.

Research with E. coli Trigger factor demonstrated that its overexpression had "marked effects on the production of these proteins in soluble forms, presumably through facilitating correct folding" , suggesting similar strategies could be effective with G. violaceus Trigger factor, particularly for cyanobacterial proteins or those with similar folding challenges.

What analytical techniques can assess the quality of purified recombinant G. violaceus Trigger factor?

Multiple analytical techniques should be employed to thoroughly characterize purified recombinant G. violaceus Trigger factor:

  • Functional assays:

    • PPIase activity using synthetic substrates

    • Chaperone activity using model aggregation-prone proteins

    • Ribosome binding assays

  • Biophysical characterization:

    • Circular dichroism (CD) spectroscopy to assess secondary structure

    • Differential scanning calorimetry (DSC) to determine thermal stability

    • Fluorescence spectroscopy to monitor tertiary structure

    • Dynamic light scattering (DLS) to assess homogeneity and aggregation state

  • Purity and integrity assessment:

    • SDS-PAGE with densitometry analysis

    • Size exclusion chromatography with multi-angle light scattering (SEC-MALS)

    • Mass spectrometry for accurate mass determination and detection of post-translational modifications

A comprehensive quality assessment combining these techniques ensures that the purified protein is properly folded, functional, and suitable for downstream applications in research or biotechnology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.